We are live on ! Find out more
JAZZ icon

Jazz Pharmaceuticals
JAZZ

373 hedge funds and large institutions have $9.87B invested in Jazz Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 51 funds opening new positions, 121 increasing their positions, 146 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

70% more first-time investments, than exits

New positions opened: 51 | Existing positions closed: 30

9% more capital invested

Capital invested by funds: $9.08B → $9.87B (+$788M)

5% more funds holding

Funds holding: 354 → 373 (+19)

17% less repeat investments, than reductions

Existing positions increased: 121 | Existing positions reduced: 146

28% less funds holding in top 10

Funds holding in top 10: 18 → 13 (-5)

52% less call options, than puts

Call options by funds: $54M | Put options by funds: $113M

Holders
373
Holders Change
+19
Holders Change %
+5.37%
% of All Funds
10.05%
Holding in Top 10
13
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-27.78%
% of All Funds
0.35%
New
51
Increased
121
Reduced
146
Closed
30
Calls
$54M
Puts
$113M
Net Calls
-$59.1M
Net Calls Change
-$28.4M

Top Buyers

1
BFA
BlackRock Fund Advisors
California
+$272M
2
BIT
BlackRock Institutional Trust
California
+$261M
3
PC
PointState Capital
New York
+$76.6M
4
BG
BlackRock Group
United Kingdom
+$71.1M
5
NC
Nicholas Company
Wisconsin
+$60.4M

Top Sellers

1
Wells Fargo
Wells Fargo
California
-$68.1M
2
JHIU
Janus Henderson Investors US
Colorado
-$65.5M
3
HM
HealthCor Management
New York
-$56.2M
4
LPC
Lone Pine Capital
Connecticut
-$45.1M
5
Franklin Resources
Franklin Resources
California
-$27.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
Calamos Advisors
76
Calamos Advisors
Illinois
$19.1M +$18.8M +104,828 +2,833%
CWG
77
C WorldWide Group
Denmark
$17.9M +$180K +1,000 +1%
PNC Financial Services Group
78
PNC Financial Services Group
Pennsylvania
$17.8M -$2.06M -11,475 -10%
BSA
79
Braun Stacey Associates
New York
$17.7M -$2.39M -13,284 -12%
Dimensional Fund Advisors
80
Dimensional Fund Advisors
Texas
$17.3M +$1.95M +10,836 +12%
Swiss National Bank
81
Swiss National Bank
Switzerland
$17.2M +$1.04M +5,800 +6%
Arrowstreet Capital
82
Arrowstreet Capital
Massachusetts
$16.7M +$17M +94,800 New
VRS
83
Virginia Retirement Systems
Virginia
$16.4M -$376K -2,095 -2%
AC
84
Ascend Capital
California
$16.3M +$16.6M +92,567 New
Millennium Management
85
Millennium Management
New York
$15.8M +$4.71M +26,214 +41%
MAA
86
Managed Account Advisors
New Jersey
$15.6M -$64.8K -361 -0.4%
Credit Agricole
87
Credit Agricole
France
$15.6M -$1.33M -7,402 -8%
CIBC Asset Management
88
CIBC Asset Management
Ontario, Canada
$14.4M -$403K -2,242 -3%
PPA
89
Parametric Portfolio Associates
Washington
$14M -$936K -5,211 -6%
O
90
OppenheimerFunds
New York
$13.6M +$3.35M +18,650 +32%
CC
91
CQS Cayman
Cayman Islands
$13.1M -$2.21M -12,310 -14%
State Board of Administration of Florida Retirement System
92
State Board of Administration of Florida Retirement System
Florida
$12.9M -$456K -2,537 -3%
BJ
93
BlackRock Japan
Japan
$12.4M +$12.7M +70,712 New
RPAM
94
Rhenman & Partners Asset Management
Sweden
$12.3M +$2.69M +15,000 +27%
RCMC
95
RK Capital Management (Colorado)
Colorado
$12.1M +$2.26M +12,600 +23%
RIM
96
Ranger Investment Management
Texas
$12.1M -$512K -2,850 -4%
CCM
97
Century Capital Management
Massachusetts
$12M -$655K -3,649 -5%
CC
98
Coastland Capital
California
$11.6M -$2.33M -13,000 -16%
Asset Management One
99
Asset Management One
Japan
$11.4M -$2.61M -14,537 -18%
APG Asset Management
100
APG Asset Management
Netherlands
$11.1M +$11.3M +62,984 New
2 3
4
5 6

JAZZ Hedge Fund Activity: Q2 2015 in Review

373 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Jazz Pharmaceuticals (JAZZ) for Q2 2015, worth a combined $9.87B — up 8.7% from $9.08B a quarter earlier.

Buyers outnumbered sellers: 51 funds opened new JAZZ positions and 30 closed out — a net gain of 21 holders — while 121 added to existing stakes and 146 trimmed.

The largest buyer was BlackRock Fund Advisors, opening a new position worth an estimated $272M. The largest seller was Wells Fargo, cutting an estimated $68.1M.

  • 373 institutional investors held Jazz Pharmaceuticals (JAZZ) as of Q2 2015, up from 354 in Q1 2015.
  • Funds reported $9.87B of Jazz Pharmaceuticals stock for Q2 2015, up 8.7% quarter-over-quarter.
  • 51 funds opened new Jazz Pharmaceuticals positions in Q2 2015 and 30 closed out, a net change of +21 holders.
  • The largest Jazz Pharmaceuticals buyer in Q2 2015 was BlackRock Fund Advisors, an estimated $272M added.
  • The largest Jazz Pharmaceuticals seller in Q2 2015 was Wells Fargo, an estimated $68.1M sold.

Based on aggregated 13F filings for Q2 2015.